The Effect of Real-time Binaural Sound on Sedation Using Dexmedetomidine
- Conditions
- Sedative Adverse Reaction
- Interventions
- Procedure: Real-time binaural soundProcedure: MusicProcedure: Control
- Registration Number
- NCT04866433
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
The aim of the study is to evaluate whether real-time binaural sound affects the dose of dexmedetomidine in patients undergoing sedation with dexmedetomidine after spinal anesthesia.
- Detailed Description
Patients undergoing sedation with dexmedetomidine after spinal anesthesia are randomly assigned to binaural group, audio group, and control group. After spinal anesthesia, SedLine continuous monitoring is started. Real-time binaural sound applied music is played to the binaural group, normal music is played to the audio group, and headphones with no sound are applied to the control group. Observer's Assessment of Alertness/Sedation Scale (OAAS) and Patient State Index (PSi) are checked every minute after loading of dexmedetomidine at the rate of 1 μg/kg for 10 minutes (6 μg/kg/hr). Loading is stopped when the OAAS score is 3 or less. Then, dexmedetomidine is continuously infused at a rate of 0.6 μg/kg/hr, and OAAS is evaluated every 30 minutes. The infusion rate is lowered (-0.1 μg/kg/hr) if OAAS is lower than 3, and increased (+0.1 μg/kg/hr) if OAAS is higher than 3. The continuous infusion rate should not exceed 1 μg/kg/hr. The total dexmedetomidine dose corrected by the patient's predicted body weight and infusion time (μg/kg/hr) was compared between groups. In addition, the loading dose (μg/kg) and continuous infusion dose (μg/kg/hr), additional sedative use, blood pressure, heart rate, ECG changes, respiratory depression, and oxygen saturation were observed. The patient's satisfaction is evaluated after the surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 189
- Adult patients undergoing sedation with dexmedetomidine during spinal anesthesia for surgery with an estimated time of 90 minutes or longer
- ASA physical status classification 3-4
- Patients with hearing loss or using hearing aids
- Patients who received narcotic analgesics or sedative drugs within 1 week
- Patients with alcohol dependence or drug dependence
- Patients with drug hypersensitivity to dexmedetomidine
- Patients with arrhythmia, cardiovascular disease, decreased cardiac function and decreased cardiac output
- Patients who are judged to be difficult to use sedative drugs due to severe respiratory disease
- Patients with liver failure
- Patients with kidney failure or on dialysis
- Patients judged to be unsuitable for the clinical trial by the researchers
- Patients whose actual operation time is less than 30 minutes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Binaural group Real-time binaural sound Play realtime binaural sound applied music through headphones Audio group Music Play music through headphones. Control group Control Wear headphones that do not produce sound.
- Primary Outcome Measures
Name Time Method Dexmedetomidine loading dose injected until OAAS reaches 3 or less (μg/kg) Intraoperative (During sedation for surgery) Dexmedetomidine loading dose injected until OAAS reaches 3 or less (μg/kg)
- Secondary Outcome Measures
Name Time Method Postanesthesia recovery score (0~10) At the postanesthesia recovery room Postanesthesia recovery score (0\~10, higher scores mean better recovery)
Observer's Assessment of Alertness/Sedation Scale (0~5) During sedation for surgery and at post anesthesia care unit (PACU) Observer's Assessment of Alertness/Sedation Scale (0, does not respond to painful trapezius squeeze; 1, responds only after painful trapezius squeeze; 2, responds only after mild prodding or shaking; 3, responds only after name is called loudly, repeatedly, or both; 4, responds lethargically to name spoken in normal tone; 5, responds readily to name spoken in normal tone)
Dexmedetomidine continuous infusion dose Intraoperative (During sedation for surgery) Total amount of dexmedetomidine infused from the end of dexmedetomidine loading to the start of suturing the surgical site
Adverse event Intraoperative (During sedation for surgery) Incidence of hypotension, hypertension, bradycardia, ECG change, need of vasopressors, respiratory suppression, desaturation
Postoperative delirium From the end of the surgery to the hospital discharge, an average of 1 week Incidence of postoperative delirium
Patient State Index (PSi) Intraoperative (During sedation for surgery) Patient State Index (PSi) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)
Number of patients requiring additional sedatives Intraoperative (During sedation for surgery) Number of patients requiring additional sedatives
Patient satisfaction Intraoperative (At the time of leaving the operating room) Patient's satisfaction with intraoperative sedation Score from 0 to 10) with intraoperative sedation measured at the time of leaving the operating room (0\~10)
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of